Skip to main content

Advertisement

Table 1 Descriptive data and prevalence

From: Prevalence of fatigue in patients 3 months after stroke and association with early motor activity: a prospective study comparing stroke patients with a matched general population cohort

   Stroke HUNT3-survey
Gender, % female   46.3 % 46.3 %
Age, mean (SD, range)   74.8 (11.4, 30.7–91.7) 74.8 (11.5, 30.7–92.5)
HUNT3 fatigue question (Do you feel, for the most part, strong and fit or tired and worn out?), n (%) 1. Very strong and fit 6 (2.3 %) 11 (4.3 %)
2. Strong and fit 29 (11.3 %) 42 (16.3 %)
3. Somewhat strong and fit 60 (23.3 %) 88 (34.2 %)
4. Somewhat in between 82 (31.9 %) 88 (34.2 %)
5. Somewhat tired and worn out 42 (16.3 %) 21 (8.2 %)
6. Tired and worn out 20 (7.8 %) 6 (2.3 %)
7. Very tired and worn out 18 (7.0 %) 1 (0.4 %)
Fatigue (HUNT3), % score ≥ 5   31.1 % 10.9 %
Fatigue (FSS-7), % score ≥ 4.0   34.6 % -
Early motor activity, mean (SD) % of day in bed 36.6 (23.4) -
% of day sitting out of bed 47.4 (19.9) -
% of day upright 10.9 (9.2) -
% of day not observed 5.1 (7.9) -
Stroke severity (NIHSS), mean (SD)   5.0 (5.0)  
Function at inclusion (mRS), median, mean (SD)   3, 3.2 (1.1) -
Function at 3 months (mRS), median, mean (SD)   2, 2.5 (1.2) -
   n (% of cohort) % reporting fatigue with HUNT3, FSS-7  
Oxford stroke classification groups TACI 17 (7 %) 41 %, 38 % -
PACI 103 (40 %) 34 %, 40 % -
LACI 58 (23 %) 24 %, 35 % -
POCI 47 (18 %) 30 %, 44 % -
Haemorrhagic 32 (13 %) 31 %, 35 % -
Co-morbidities, % of cohort Hypertension 68 % 48 %
Heart failure 10 % 7 %
Myocardial infarct 19 % 14 %
Lung disease (including asthma and COPD) 12 % 14 %
Kidney disease 3 % 2 %
Diabetes mellitus 15 % 11 %
Cancer 18 % 9 %
Connective tissue disease (including rheumatoid arthritis and spondylitis 8 % 8 %
  1. Descriptive data, prevalence of fatigue and early motor activity data are provided for the stroke patients (n = 257) and their age/gender-matched counterparts (n = 257) from HUNT3-Survey
  2. FSS-7 7-item Fatigue Severity Scale, mRS modified Rankin Scale (range of scores 0–5), NIHSS National Institutes of Health Stroke Scale (range of scores 0–42), COPD chronic obstructive pulmonary disease